Climb Biotherapeutics, Inc. logo

Climb Biotherapeutics, Inc. (CLYM)

Market Closed
18 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
14. 05
-0.01
-0.0711%
$
805.12M Market Cap
- P/E Ratio
- Div Yield
4.05M Volume
0 Eps
$ 14.06
Previous Close
Analysts:
Add Transaction
Day Range
13.92 14.44
Year Range
1.54 18.33
Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Climb Biotherapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Joseph Castro
Joseph Castro Nuveen LLC
85,935 $1.12M $1.2M $74,763.85 6.67%
KJ
Ken Joseph Braidwel LLP
2.8M $27.01M $39.21M $12.2M 45.18%
George Song
George Song Superstring Capital Management LP
521,082 $5.56M $7.3M $1.74M 31.33%
Drew Phillips
Drew Phillips Fortitude Family Office LLC
92 $630 $1,271.44 $641.44 101.82%
Kevin Roan
Kevin Roan Stempoint Capita LLP
742,745 $9.69M $10.41M $726,033.02 7.5%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
886 $11,553 $12,244.52 $691.52 5.99%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
821 $10,706 $11,756.72 $1,050.72 9.81%
AMY TEH
AMY TEH Arrowpoint Investment Partners (Singapore) Pte. Ltd.
15,241 $104,401.16 $218,133.76 $113,732.6 108.94%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
10,390 $135,486 $147,729.18 $12,243.18 9.04%
Kirsten Syverson
Kirsten Syverson Integrated Quantitative Investments LLC
31,406 $409,534 $445,808.17 $36,274.17 8.86%
SummitTX Capital LP
SummitTX Capital LP SummitTX Capital LP
10,791 $140,715 $153,178.24 $12,463.24 8.86%